Trusted Resources: News & Events
Latest announcements and gatherings
MARAC Advisory Statement: Monoclonal Antibodies Against SARS-CoV-2
August 26, 2021 – The Sickle Cell Disease Association of America Medical and Research Advisory Committee has released a statement with updated COVID-19 guidance.
MARAC recommends that people with sickle cell disease should have access to monoclonal antibody (mAbs) treatment according to established guidelines, to prevent mild COVID from progressing to severe disease.
Read the full recommendations for providers, policy makers and patients.
+myBinderRelated Content
-
Sickle Cell Advocacy and Management InitiativeSickle Cell Advocacy and Management Init...
-
Cure Sickle Cell FoundationWe are dedicated to promoting awareness ...
-
Caregivers and Sickle Cell DiseaseCaregivers are responsible for the physi...
-
Eileen MurrayEileen Murray is currently working as Ce...
-
In Support of Rare Disease Patients Impacted by COVID-19, NORD Launches Premium and Limited Medical Relief ProgramUnited with more than 25 million America...
-
Emmaus Life Sciences Launches Its Commercial Co-Payment Assistance Program for Endari™Emmaus Life Sciences, Inc., a leader in ...
-
Crisis OverCrisis Over is a sickle cell disease blo...
Don’t forget to join the oneSCDvoice community!
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.